Compare ALEC & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALEC | BHST |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.2M | 137.1M |
| IPO Year | 2019 | N/A |
| Metric | ALEC | BHST |
|---|---|---|
| Price | $1.45 | $5.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $3.50 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.7M | 74.3K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,048,000.00 | $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | $160.66 | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 12.26 | ★ 45.88 |
| 52 Week Low | $0.87 | $4.72 |
| 52 Week High | $3.40 | $12.80 |
| Indicator | ALEC | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 35.11 |
| Support Level | $1.18 | $6.12 |
| Resistance Level | $1.39 | $6.89 |
| Average True Range (ATR) | 0.10 | 0.55 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 82.22 | 20.99 |
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.